Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
INDAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/163140
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide a compound that exhibits an H-PGDS inhibitory activity. The present invention relates to a compound expressed by formula [I] or a pharmaceutically acceptable salt thereof (in the formula, each reference sign is as defined in the specification).

Inventors:
NAGAMOTO YUKI (JP)
TAKAGI MASAKI (JP)
MATSUMURA KOJI (JP)
ITO HIROTSUGU (JP)
ITO KEISUKE (JP)
OYAMA YUKI (JP)
Application Number:
PCT/JP2023/006921
Publication Date:
August 31, 2023
Filing Date:
February 27, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JAPAN TOBACCO INC (JP)
International Classes:
C07D403/04; A61K31/416; A61K31/4439; A61K31/444; A61K31/506; A61K31/5377; A61P9/00; A61P11/00; A61P11/06; A61P21/00; A61P37/08; C07D231/56; C07D401/04; C07D401/14; C07D403/14; C07D405/14; C07D409/14; C07D413/14; C07D451/04; C07D471/04
Domestic Patent References:
WO2021256569A12021-12-23
WO2022194781A12022-09-22
Foreign References:
JP2021534166A2021-12-09
Other References:
TRUJILLO, JOHN I. ET AL.: "Investigation of the binding pocket of human hematopoietic prostaglandin (PG) D2 synthase (hH-PGDS): A tale of two waters", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 22, no. 11, 2012, pages 3795 - 3799, XP028423366, DOI: 10.1016/j.bmcl. 2012.04.00 4
CHRIST, ANGELIKA N. ET AL.: "Development and Characterization of New Inhibitors of the Human and Mouse Hematopoietic Prostaglandin D2 Synthases", JOURNAL OF MEDICINAL CHEMISTRY, vol. 53, no. 15, 2010, pages 5536 - 5548, XP055002058, DOI: 10.1021/jm100194a
Attorney, Agent or Firm:
KAMADA, Mitsunori et al. (JP)
Download PDF: